Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Liying Zhang
Affiliation
The Fifth Affiliated Hospital, Sun Yat-sen University
ORCID
Career Start Year
2004
Papers
81
H Index
32
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36629093
Prognosis prediction and risk factors for triple-negative breast cancer patients with brain metastasis: A population-based study.
Cancer Med
2023
36691871
Characterization of a germline variant MSH6 c.4001GÂ >â¿¿C in a Lynch syndrome family.
Mol Genet Genomic Med
2023
34667028
Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.
Clin Cancer Res
2022
35833951
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
Clin Cancer Res
2022
35971132
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.
Genome Med
2022
33300245
Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.
Hum Mutat
2021
33907319
Correction to: Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) variant.
Eur J Hum Genet
2021
33822432
Insertion of an SVA element in MSH2 as a novel cause of Lynch syndrome.
Genes Chromosomes Cancer
2021
33619332
Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant.
Eur J Hum Genet
2021
34405229
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.
J Natl Cancer Inst
2021
34635660
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.
NPJ Breast Cancer
2021
34741162
The context-specific role of germline pathogenicity in tumorigenesis.
Nat Genet
2021
34308366
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.
Nat Cancer
2021
33169439
The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response.
Hum Mutat
2021
33452952
The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer.
Breast Cancer Res Treat
2021
31444830
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma.
Hum Mutat
2020
32012241
Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
Cancer
2020
31794323
Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.
J Clin Oncol
2020
31881335
Reliable Clinical MLH1 Promoter Hypermethylation Assessment Using a High-Throughput Genome-Wide Methylation Array Platform.
J Mol Diagn
2020
33058565
Insertion of an Alu-like element in MLH1 intron 7 as a novel cause of Lynch syndrome.
Mol Genet Genomic Med
2020
32444418
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
Clin Cancer Res
2020
32356167
Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family.
Fam Cancer
2020
30643016
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
Cancer Res
2019
31648317
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.
Blood Adv
2019
32775946
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.
JCO Precis Oncol
2019
32923861
Pathogenic Loss-of-Function Germline <i>TERT</i> Mutations in Patients With Solid Tumors.
JCO Precis Oncol
2019
30255452
A synonymous germline variant PALB2 c.18G>T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancers.
Breast Cancer Res Treat
2019
30166615
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas.
Mod Pathol
2019
31323388
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
J Thorac Oncol
2019
31175329
Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade.
Mod Pathol
2019
30894706
Correction: Toward automation of germline variant curation in clinical cancer genetics.
Genet Med
2019
30787465
Toward automation of germline variant curation in clinical cancer genetics.
Genet Med
2019
30376427
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
J Clin Oncol
2019
30523343
Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework.
Genet Med
2019
28819720
Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.
Fam Cancer
2018
30068732
Germline <i>SDHA</i> mutations in children and adults with cancer.
Cold Spring Harb Mol Case Stud
2018
29872864
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.
JAMA Oncol
2018
29978187
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
JAMA Oncol
2018
30311380
Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel.
Hum Mutat
2018
30311375
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
Hum Mutat
2018
30311369
Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.
Hum Mutat
2018
29185120
Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.
Breast Cancer Res Treat
2018
29122777
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.
Cancer Discov
2018
29293272
The emerging significance of secondary germline testing in cancer genomics.
J Pathol
2018
28555354
Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.
Fam Cancer
2018
28526081
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
BMC Med Genomics
2017
30211344
Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data.
JCO Precis Oncol
2017
28873162
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
JAMA
2017
28825054
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.
JCO Precis Oncol
2017
28609363
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.
Pancreas
2017
1 - 50 of 81
Column Actions
Search
Recommended Authors
Karen Ouyang
Invitae Corporation
Career Start Year
2013
Number of shared co-authors
2
Aurelie Vogt
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year
2012
Number of shared co-authors
13
Sarah M Nielsen
Invitae Corporation
Career Start Year
2011
Number of shared co-authors
24
Sigve Nakken
University of Oslo
Career Start Year
2007
Number of shared co-authors
1
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
0
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
31
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year
2005
Number of shared co-authors
14
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
21
Matthew B Yurgelun
34Dana-Farber/Brigham and Women's Cancer Center.
Career Start Year
2005
Number of shared co-authors
10
David Jones
Wellcome Sanger Institute
Career Start Year
2005
Number of shared co-authors
7
Rebecca Nagy
Guardant Health Inc.
Career Start Year
2004
Number of shared co-authors
15
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
0
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year
2003
Number of shared co-authors
4
Andrew Menzies
Wellcome Sanger Institute
Career Start Year
2002
Number of shared co-authors
6
Jon Teague
Wellcome Sanger Institute
Career Start Year
2002
Number of shared co-authors
9
George Chong
Lady David Institute for Medical Research, Jewish General Hospital
Career Start Year
2001
Number of shared co-authors
12
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year
1998
Number of shared co-authors
4
Edward D Esplin
Invitae Corporation
Career Start Year
1998
Number of shared co-authors
6
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year
1998
Number of shared co-authors
42
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
22
Adam Butler
Wellcome Sanger Institute
Career Start Year
1996
Number of shared co-authors
9
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year
1995
Number of shared co-authors
10
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
3
Janine Senz
University of British Columbia
Career Start Year
1994
Number of shared co-authors
30
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
30
Ming K Lee
University of Washington
Career Start Year
1988
Number of shared co-authors
18
Michael R Stratton
Wellcome Sanger Institute
Career Start Year
1987
Number of shared co-authors
31
Alvaro N A Monteiro
H. Lee Moffitt Cancer Center & Research Institute
Career Start Year
1985
Number of shared co-authors
38
David A Wheeler
Baylor College of Medicine
Career Start Year
1984
Number of shared co-authors
25
Stephen N Thibodeau
Mayo Clinic
Career Start Year
1978
Number of shared co-authors
34
row(s) 1 - 30 of 30
Collaborators
Michael F Walsh
Memorial Sloan Kettering Cancer Center
Co-authored papers
23
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers
18
Michael F Berger
Co-authored papers
16
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers
7
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers
6
Sharon E Plon
Baylor College of Medicine
Co-authored papers
6
Kasmintan A Schrader
University of British Columbia
Co-authored papers
6
Chaitanya Bandlamudi
Co-authored papers
5
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers
5
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
4
Kristy Lee
The University of North Carolina at Chapel Hill
Co-authored papers
4
Chimene Kesserwan
National Institutes of Health
Co-authored papers
3
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers
3
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers
3
José Baselga
Co-authored papers
3
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Susan M Domchek
Co-authored papers
2
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers
2
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Co-authored papers
2
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers
2
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Zachary J Heins
Boston University
Co-authored papers
2
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
1 - 30